Home
About
FAQ
History (9)
RSR' pattern and the risk of mortality in men and women free of cardiovascular disease.
A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Soft Tissue Open Surgery.
The ketogenic diet for the treatment of pediatric status epilepticus.
Recurrent Glioblastoma Treated with Recombinant Poliovirus.
Granulocytes as an effector mechanism of BCG therapy for bladder cancer.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Granulocytes as an effector mechanism of BCG therapy for bladder cancer.
Davis RL, Le W, Cui Z. Granulocytes as an effector mechanism of BCG therapy for bladder cancer. Med Hypotheses. 2017 Jul; 104:166-169.
View in:
PubMed
subject areas
Animals
BCG Vaccine
Cell Line, Tumor
Cytokines
Granulocytes
Humans
Mice
Models, Theoretical
Neutrophils
Treatment Outcome
Urinary Bladder
Urinary Bladder Neoplasms
authors with profiles
Ronald L. Davis MD